Flagship
Triple Weight Loss Action (Tirzepatide)
Dual GIP/GLP-1 receptor agonist. Reduces appetite and improves glucose regulation.
$189.00
30 ml
Weight Loss
Satiety. Balance. Control.
GLP-1 and dual-incretin peptides that primarily reduce appetite, increase satiety, and improve glucose regulation.
GLP-1
Incretin pathway
Satiety
Appetite control
Glucose
Regulation support
Catalog
4 products
Inquire →
Tirzepatide
Dual GIP/GLP-1 agonist studied for weight management and glycemic control.
$149.00
10 mg / vial
Bestseller
Semaglutide
GLP-1 receptor agonist that increases satiety and supports glucose regulation.
$119.00
5 mg / vial
Liraglutide
Daily GLP-1 analog studied for appetite reduction and metabolic support.
$98.00
10 mg / vial
These peptides act on appetite and glucose pathways. Some are FDA-approved medicines; availability may require a prescription from a licensed professional.